SLC13A5 and type 2 diabetes mellitus: Of even more concern is that loss-of-function mutations in human SLC13A5/INDY/Mindy do not lead to resistance to type 2 diabetes and instead cause neonatal epilepsy and several other developmental defects (Kopel et al., 2021).